Truist Financial Corp Has $5.40 Million Stock Position in Chemed Co. (NYSE:CHE)

Truist Financial Corp raised its holdings in shares of Chemed Co. (NYSE:CHE) by 2.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,233 shares of the company’s stock after buying an additional 223 shares during the quarter. Truist Financial Corp owned about 0.06% of Chemed worth $5,399,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of CHE. Wealth Alliance boosted its holdings in Chemed by 3.0% in the 4th quarter. Wealth Alliance now owns 578 shares of the company’s stock valued at $338,000 after purchasing an additional 17 shares during the period. Fifth Third Bancorp grew its position in Chemed by 0.5% during the third quarter. Fifth Third Bancorp now owns 3,914 shares of the company’s stock worth $2,034,000 after buying an additional 21 shares in the last quarter. Legacy Wealth Asset Management LLC increased its stake in Chemed by 0.9% during the fourth quarter. Legacy Wealth Asset Management LLC now owns 2,275 shares of the company’s stock valued at $1,330,000 after acquiring an additional 21 shares during the period. Signaturefd LLC increased its stake in Chemed by 5.8% during the fourth quarter. Signaturefd LLC now owns 385 shares of the company’s stock valued at $225,000 after acquiring an additional 21 shares during the period. Finally, Kestra Advisory Services LLC raised its holdings in Chemed by 3.8% in the 3rd quarter. Kestra Advisory Services LLC now owns 634 shares of the company’s stock valued at $329,000 after acquiring an additional 23 shares in the last quarter. 95.85% of the stock is owned by institutional investors.

Chemed Price Performance

Chemed stock opened at $561.65 on Monday. The business has a 50 day simple moving average of $620.66 and a 200 day simple moving average of $593.70. The company has a market capitalization of $8.50 billion, a PE ratio of 30.23, a price-to-earnings-growth ratio of 2.29 and a beta of 0.46. Chemed Co. has a one year low of $492.84 and a one year high of $654.62.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Wednesday, April 24th. The company reported $4.68 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.09 by ($0.41). Chemed had a net margin of 12.36% and a return on equity of 30.52%. The company had revenue of $589.23 million for the quarter, compared to the consensus estimate of $587.18 million. Equities analysts anticipate that Chemed Co. will post 21.72 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Monday, February 26th were paid a dividend of $0.40 per share. The ex-dividend date was Friday, February 23rd. This represents a $1.60 annualized dividend and a yield of 0.28%. Chemed’s dividend payout ratio is 8.61%.

Analyst Upgrades and Downgrades

CHE has been the topic of a number of research reports. Oppenheimer boosted their price objective on Chemed from $625.00 to $650.00 and gave the company an “outperform” rating in a research report on Thursday, February 29th. Royal Bank of Canada increased their price objective on shares of Chemed from $604.00 to $712.00 and gave the company an “outperform” rating in a research note on Monday, March 4th. Finally, StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday.

Insiders Place Their Bets

In other news, EVP Spencer S. Lee sold 2,000 shares of the business’s stock in a transaction that occurred on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total value of $1,283,300.00. Following the transaction, the executive vice president now directly owns 20,760 shares of the company’s stock, valued at approximately $13,320,654. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, EVP Spencer S. Lee sold 2,000 shares of the firm’s stock in a transaction on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total transaction of $1,283,300.00. Following the completion of the sale, the executive vice president now directly owns 20,760 shares of the company’s stock, valued at approximately $13,320,654. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Michael D. Witzeman sold 2,650 shares of the business’s stock in a transaction on Thursday, March 21st. The stock was sold at an average price of $643.14, for a total value of $1,704,321.00. Following the completion of the transaction, the chief financial officer now directly owns 2,882 shares in the company, valued at approximately $1,853,529.48. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 15,808 shares of company stock valued at $10,184,531. 3.32% of the stock is currently owned by insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.